Amgen has won a key patent victory over Sandoz in a dispute over biologic Enbrel.
Labrador Diagnostics has dropped its controversial patent complaint against COVID-19 test developer BioMerieux.
Johnson & Johnson has accused a medical supplier of distributing counterfeit surgical tools that are “bacterially contaminated and critically defective”.
Latham & Watkins has added two life sciences-focused litigators, Arlene Chow and Ernest Yakob, to its New York office.
Gilead Sciences has begun a potential takeover of Pionyr Immunotherapeutics after it agreed to pay $275 million for a 49.9% equity stake in the cancer research company.
3M has settled with two companies it had accused of reselling N95 masks at inflated prices amid the COVID-19 pandemic.
Mylan has succeeded in having a key Biogen patent covering multiple sclerosis drug Tecfidera invalidated by a US federal court.
Roche Diabetes Care, a subsidiary of Switzerland-based Roche, has accused medical device company Insulet of infringing a patent covering a blood glucose level monitor.
MicroPort Orthopedics has sued rival Medacta, accusing it of providing surgeons with “knock-off copies and defaced versions” of MicroPort’s patented surgical tools.
Genetic sequencing company Illumina has obtained a preliminary injunction against its China-based rival BGI.